These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 15946653

  • 41. Apoferritin attenuates experimental allergic encephalomyelitis in SJL mice.
    LeVine SM, Maiti S, Emerson MR, Pedchenko TV.
    Dev Neurosci; 2002; 24(2-3):177-83. PubMed ID: 12401956
    [Abstract] [Full Text] [Related]

  • 42. Differential anxiety-like responses in NOD/ShiLtJ and C57BL/6J mice following experimental autoimmune encephalomyelitis induction and oral gavage.
    Kocovski P, Dang PT, D'Souza CS, Stamper CE, Hale MW, Orian JM.
    Lab Anim; 2018 Oct; 52(5):470-478. PubMed ID: 29444620
    [Abstract] [Full Text] [Related]

  • 43. Oral administration of the oxidant-scavenger N-acetyl-L-cysteine inhibits acute experimental autoimmune encephalomyelitis.
    Lehmann D, Karussis D, Misrachi-Koll R, Shezen E, Ovadia H, Abramsky O.
    J Neuroimmunol; 1994 Feb; 50(1):35-42. PubMed ID: 8300856
    [Abstract] [Full Text] [Related]

  • 44. Antiatherogenic Roles of Dietary Flavonoids Chrysin, Quercetin, and Luteolin.
    Basu A, Das AS, Majumder M, Mukhopadhyay R.
    J Cardiovasc Pharmacol; 2016 Jul; 68(1):89-96. PubMed ID: 27385185
    [Abstract] [Full Text] [Related]

  • 45. Luteolin as a therapeutic option for multiple sclerosis.
    Theoharides TC.
    J Neuroinflammation; 2009 Oct 13; 6():29. PubMed ID: 19825165
    [Abstract] [Full Text] [Related]

  • 46. Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin.
    Ginwala R, Bhavsar R, Chigbu DI, Jain P, Khan ZK.
    Antioxidants (Basel); 2019 Feb 05; 8(2):. PubMed ID: 30764536
    [Abstract] [Full Text] [Related]

  • 47. Correction: PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis.
    Webb LM, Amici SA, Jablonski KA, Savardekar H, Panfil AR, Li L, Zhou W, Peine K, Karkhanis V, Bachelder EM, Ainslie KM, Green PL, Li C, Baiocchi RA, Guerau-de-Arellano M.
    J Immunol; 2017 Oct 15; 199(8):3004. PubMed ID: 29018151
    [No Abstract] [Full Text] [Related]

  • 48. [On the effects of trihydroxy-ethylrutin on experimental edema of the rat leg].
    FORMANEK K, HOELLER H.
    Wien Med Wochenschr; 1960 Sep 03; 110():697-9. PubMed ID: 13700805
    [No Abstract] [Full Text] [Related]

  • 49. Quercetin attenuates zymosan-induced arthritis in mice.
    Guazelli CFS, Staurengo-Ferrari L, Zarpelon AC, Pinho-Ribeiro FA, Ruiz-Miyazawa KW, Vicentini FTMC, Vignoli JA, Camilios-Neto D, Georgetti SR, Baracat MM, Casagrande R, Verri WA.
    Biomed Pharmacother; 2018 Jun 03; 102():175-184. PubMed ID: 29554596
    [Abstract] [Full Text] [Related]

  • 50. Immunomodulatory Effects of Anadenanthera colubrina Bark Extract in Experimental Autoimmune Encephalomyelitis.
    Ramos KA, Soares IGM, Oliveira LMA, Braga MA, Soares PPC, Guarneire GJ, Scherrer EC, Silva FS, Lima NM, La Porta FA, de Jesus A S Andrade T, Preet G, Castro SBR, Alves CCS, Carli AP.
    Curr Issues Mol Biol; 2024 Aug 10; 46(8):8726-8740. PubMed ID: 39194732
    [Abstract] [Full Text] [Related]

  • 51. Neuroprotective effects of rutin against cuprizone-induced multiple sclerosis in mice.
    Nicola MA, Attaai AH, Abdel-Raheem MH, Mohammed AF, Abu-Elhassan YF.
    Inflammopharmacology; 2024 Apr 10; 32(2):1295-1315. PubMed ID: 38512652
    [Abstract] [Full Text] [Related]

  • 52. Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis.
    Kujawa D, Laczmanski L, Budrewicz S, Pokryszko-Dragan A, Podbielska M.
    Gut Microbes; 2023 Dec 10; 15(2):2274126. PubMed ID: 37979154
    [Abstract] [Full Text] [Related]

  • 53. Methyl-CpG-Binding Protein 2 Emerges as a Central Player in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
    Mehmood A, Shah S, Guo RY, Haider A, Shi M, Ali H, Ali I, Ullah R, Li B.
    Cell Mol Neurobiol; 2023 Nov 10; 43(8):4071-4101. PubMed ID: 37955798
    [Abstract] [Full Text] [Related]

  • 54. Dietary Polyphenols, Microbiome, and Multiple Sclerosis: From Molecular Anti-Inflammatory and Neuroprotective Mechanisms to Clinical Evidence.
    La Rosa G, Lonardo MS, Cacciapuoti N, Muscariello E, Guida B, Faraonio R, Santillo M, Damiano S.
    Int J Mol Sci; 2023 Apr 14; 24(8):. PubMed ID: 37108412
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Detailed approach toward the anti-hyperglycemic potential of Sterculia diversifolia G. Don against alloxan-induced in vivo hyperglycemia model.
    Fazle R, Amir Z, Amna N, Achyut A, Irfan U, Shafiq Ur R.
    J Tradit Chin Med; 2022 Feb 14; 42(1):17-22. PubMed ID: 35294118
    [Abstract] [Full Text] [Related]

  • 57. Curcumin β-D-Glucuronide Modulates an Autoimmune Model of Multiple Sclerosis with Altered Gut Microbiota in the Ileum and Feces.
    Khadka S, Omura S, Sato F, Nishio K, Kakeya H, Tsunoda I.
    Front Cell Infect Microbiol; 2021 Feb 14; 11():772962. PubMed ID: 34926318
    [Abstract] [Full Text] [Related]

  • 58. Targeting Nuclear Factor-Kappa B Signaling Pathway by Curcumin: Implications for the Treatment of Multiple Sclerosis.
    Gachpazan M, Habbibirad S, Kashani H, Jamialahmadi T, Rahimi HR, Sahebkar A.
    Adv Exp Med Biol; 2021 Feb 14; 1291():41-53. PubMed ID: 34331683
    [Abstract] [Full Text] [Related]

  • 59. Role of diet in regulating the gut microbiota and multiple sclerosis.
    Sanchez JMS, DePaula-Silva AB, Libbey JE, Fujinami RS.
    Clin Immunol; 2022 Feb 14; 235():108379. PubMed ID: 32156562
    [No Abstract] [Full Text] [Related]

  • 60. An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events.
    Cordaro M, Cuzzocrea S, Crupi R.
    Antioxidants (Basel); 2020 Mar 05; 9(3):. PubMed ID: 32150935
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.